Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reliability analysis of first and second generation PSA assays.

L F Wymenga1, K Groenier, P Visser-van Brummen

  • 1Department of Urology, Martini Hospital, NL-9700 RM Groningen, The Netherlands.

The Canadian Journal of Urology
|December 18, 2000
PubMed
Summary

First and second generation prostate-specific antigen (PSA) assays (IMx and IMMULITE) show excellent correlation and are largely equivalent for most men. Minor differences between these PSA tests are unlikely to be clinically significant.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complications and side effects: a problem in general practice?

The International journal of risk & safety in medicine·2013
Same author

[Surprises during urological interventions due to incomplete medical histories].

Nederlands tijdschrift voor geneeskunde·2003
Same author

[The use of corticosteroid cream to treat phimosis].

Nederlands tijdschrift voor geneeskunde·2003
Same author

Ultrasound-guided seminal vesicle biopsies in prostate cancer.

Prostate cancer and prostatic diseases·2002
Same author

Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase.

BJU international·2001
Same author

Pretreatment levels of urinary deoxypyridinoline as a potential marker in patients with prostate cancer with or without bone metastasis.

BJU international·2001

Area of Science:

  • Clinical chemistry
  • Biomarker analysis
  • Prostate cancer diagnostics

Background:

  • Prostate-specific antigen (PSA) is a key biomarker for prostate health.
  • Evaluating the reliability of different PSA assay generations is crucial for accurate clinical interpretation.

Purpose of the Study:

  • To assess the reliability and compare pretreatment serum PSA levels between first-generation (IMx) and second-generation (IMMULITE) PSA assays.

Main Methods:

  • Compared serum PSA levels from 545 men using IMx and IMMULITE assays.
  • Analyzed PSA ranges across different prostatic histologies (benign prostatic hyperplasia, prostate cancer).
  • Utilized receiver operating characteristic (ROC) curve analysis to evaluate assay performance.

Main Results:

Related Experiment Videos

  • Demonstrated excellent correlation (r > 0.97) between IMx and IMMULITE PSA assays across the tested range.
  • Found equivalent slopes in PSA ranges for benign prostatic hyperplasia and prostate cancer patients.
  • Reported non-significant differences in the area under the ROC curve (IMx: 0.7860, IMMULITE: 0.7810, p=0.87).

Conclusions:

  • First-generation (IMx) and second-generation (IMMULITE) PSA assays are equivalent for the majority of men.
  • Small assay differences are generally not clinically significant but warrant consideration for sequential monitoring in individual patients.